Europe — EMA
Vesanoid (Tretinoin)
Vesanoid (tretinoin) is a prescription retinoid used to treat acute promyelocytic leukemia. This oral medication helps reduce cancer cell growth by promoting no
Request sourcing
What is Tretinoin?
Vesanoid (tretinoin) is a prescription retinoid used to treat acute promyelocytic leukemia. This oral medication helps reduce cancer cell growth by promoting normal cell differentiation. It is taken under medical supervision for best results.
What is Tretinoin used for?
Vesanoid (tretinoin) is primarily used to treat acute promyelocytic leukemia, a type of blood cancer. It works by encouraging immature white blood cells to mature, helping to slow disease progression. This medication is prescribed when standard treatments are not suitable.
What are the side effects of Tretinoin?
Vesanoid may cause mild to moderate side effects such as headache, fever, or skin dryness. Some users report bone or joint pain, nausea, or fatigue during treatment. These effects vary by individual and should be monitored by a healthcare provider.
What precautions apply to Tretinoin?
Vesanoid requires careful handling due to its effects on blood cells and potential for birth defects. Patients should avoid pregnancy during and shortly after treatment. Regular blood tests are essential to track white blood cell counts and liver function.
What does Tretinoin interact with?
Vesanoid can interact with other medications that affect liver enzymes, such as certain antibiotics or antifungals. Combining it with vitamin A supplements or other retinoids may increase side effects. Always inform your doctor about all medications and supplements in use.
